Tenofovir-based PrEP for COVID-19: an untapped opportunity?

AIDS. 2021 Jul 15;35(9):1509-1511. doi: 10.1097/QAD.0000000000002877.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • COVID-19*
  • Emtricitabine
  • HIV Infections* / drug therapy
  • Humans
  • Medication Adherence
  • Pre-Exposure Prophylaxis*
  • SARS-CoV-2
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Tenofovir
  • Emtricitabine